dc.creator | Bakal, David R. | |
dc.creator | Coelho, Lara E. | |
dc.creator | Luz, Paula Mendes | |
dc.creator | Clark, Jesse L. | |
dc.creator | De Boni, Raquel Brandini | |
dc.creator | Cardoso, Sandra W. | |
dc.creator | Santos, Valdiléa Gonçalves Veloso dos | |
dc.creator | Lake, Jordan E. | |
dc.creator | Grinsztejn, Beatriz | |
dc.date | 2018-10-08T15:02:09Z | |
dc.date | 2018-10-08T15:02:09Z | |
dc.date | 2018 | |
dc.date.accessioned | 2023-09-26T23:37:30Z | |
dc.date.available | 2023-09-26T23:37:30Z | |
dc.identifier | BAKAL, David R. et al. Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors. Journal of Antimicrobial Chemotherapy, v. 73, n. 8, p. 2177-2185, 2018. | |
dc.identifier | 0305-7453 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/29426 | |
dc.identifier | 10.1093/jac/dky145 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8892522 | |
dc.description | Background: Obesity rates are increasing among HIV-infected individuals, but risk factors for obesity development on ART remain unclear. Objectives: In a cohort of HIV-infected adults in Rio de Janeiro, Brazil, we aimed to determine obesity rates before and after ART initiation and to analyse risk factors for obesity on ART. Methods: We retrospectively analysed data from individuals initiating ART between 2000 and 2015. BMI was calculated at baseline (time of ART initiation). Participants who were non-obese at baseline and had 90 days of ART exposure were followed until the development of obesity or the end of follow-up. Obesity incidence rates were estimated using Poisson regression models and risk factors were assessed using Cox regression
models. Results: Of participants analysed at baseline (n " 1794), 61.3% were male, 48.3% were white and 7.9% were obese. Among participants followed longitudinally (n " 1567), 66.2% primarily used an NNRTI, 32.9% a PI and 0.9% an integrase strand transfer inhibitor (INSTI); 18.3% developed obesity and obesity incidence was 37.4 per 1000 person-years. In multivariable analysis, the greatest risk factor for developing obesity was the use of an INSTI as the primary ART core drug (adjusted HR 7.12, P , 0.0001); other risk factors included younger age, female sex, higher baseline BMI, lower baseline CD4! T lymphocyte count, higher baseline HIV-1 RNA, hypertension and diabetes mellitus. Conclusions: Obesity following ART initiation is frequent among HIV-infected adults. Key risk factors include female sex, HIV disease severity and INSTI use. Further research regarding the association between INSTIs and the development of obesity is needed. | |
dc.description | 2028-08-30 | |
dc.format | application/pdf | |
dc.language | eng | |
dc.rights | restricted access | |
dc.subject | Obesity | |
dc.subject | HIV | |
dc.subject | Body mass index procedure | |
dc.subject | Follow-up | |
dc.subject | Integrase inhibitors | |
dc.subject | HIV infections | |
dc.title | Obesity following ART initiation is common and influenced by both traditional and HIV-/ART-specific risk factors | |
dc.type | Article | |